Sep 15, 2026 03:11PM
Sep 15, 2026 03:11PM
Sep 11, 2026 07:00AM
Sep 11, 2026 07:00AM
Sep 11, 2026 07:00AM
Aug 26, 2026 06:43AM
Aug 17, 2026 07:00AM NRx Pharmaceuticals (Nasdaq:NRXP) Reports Second Quarter 2026 Financial Results and Provides Corporate Update; Conference Call to be Held on Monday, August 17th at 4:30pm ET
Aug 10, 2026 06:50AM
Aug 7, 2026 04:01PM
Aug 7, 2026 07:01AM
Aug 7, 2026 07:00AM
Jun 25, 2026 04:01PM
Jun 25, 2026 04:01PM
Jun 25, 2026 07:00AM HOPE Therapeutics begins patient TMS treatments with Zeta navigation
Jun 25, 2026 07:00AM
Jun 25, 2026 07:00AM
Jun 23, 2026 11:10AM
Jun 23, 2026 11:05AM
Jun 22, 2026 07:00AM
Jun 5, 2026 08:52AM
Jun 5, 2026 08:50AM NRx Pharmaceuticals (Nasdaq:NRXP) notes presentation by Osmind, Inc. of IV Ketamine Efficacy vs. Nasal esketamine Efficacy at American Society of Clinical Psychopharmacology.
May 27, 2026 07:02AM
May 27, 2026 07:00AM
May 27, 2026 07:00AM
May 18, 2026 07:00AM
May 7, 2026 08:01AM
May 7, 2026 08:00AM
May 5, 2026 07:00AM NRX Pharmaceuticals begins commercial manufacturing for preservative-free ketamine
May 5, 2026 07:00AM
May 1, 2026 02:30PM
Apr 27, 2026 06:49AM
Apr 22, 2026 07:04AM
Apr 22, 2026 07:00AM
Apr 20, 2026 07:00AM
Apr 15, 2026 07:01AM NRx Pharmaceuticals forms defense subsidiary for military therapy research
Apr 15, 2026 07:00AM
Apr 6, 2026 07:00AM
Apr 6, 2026 07:00AM
Mar 24, 2026 12:58PM
Mar 24, 2026 07:00AM
Mar 17, 2026 07:00AM
Mar 17, 2026 07:00AM NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Bioequivalence Determination by Office of Generic Drugs for NRx’s Preservative-Free Ketamine Application
Mar 16, 2026 07:00AM
Mar 16, 2026 07:00AM
Mar 9, 2026 07:00AM
Mar 4, 2026 06:44AM
Mar 2, 2026 07:03AM
Mar 2, 2026 07:00AM
Feb 27, 2026 09:04AM NRx Pharmaceuticals meets with FDA on suicidal depression drug
Feb 27, 2026 09:00AM

331,504 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All